|
1
|
Cholinergic effects on fear conditioning II: nicotinic and muscarinic modulations of atropine-induced disruption of the degraded contingency effect.
|
Psychopharmacology (Berl)
|
2005
|
1.43
|
|
2
|
In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats.
|
Anesth Analg
|
2002
|
1.06
|
|
3
|
Involvement of the basal cholinergic forebrain in the mediation of general (propofol) anesthesia.
|
Anesthesiology
|
2008
|
0.87
|
|
4
|
Effect of a nonsedative dose of propofol on memory for aversively loaded information in rats.
|
Anesthesiology
|
2002
|
0.84
|
|
5
|
Reciprocal relationships between general (Propofol) anesthesia and circadian time in rats.
|
Neuropsychopharmacology
|
2006
|
0.83
|
|
6
|
Associative deficit accounts of disrupted latent inhibition and blocking in schizophrenia.
|
Neurosci Biobehav Rev
|
2002
|
0.83
|
|
7
|
Delayed aversive effects of high-dose fentanyl. Prevention by a polyamine-deficient diet.
|
Behav Brain Res
|
2008
|
0.77
|
|
8
|
Cholinergic effects on fear conditioning I: the degraded contingency effect is disrupted by atropine but reinstated by physostigmine.
|
Psychopharmacology (Berl)
|
2005
|
0.77
|
|
9
|
Fos immunolabelling evidence for brain regions involved in the Pavlovian degraded contingency effect and in its disruption by atropine.
|
Neuropharmacology
|
2006
|
0.75
|
|
10
|
Prefrontal cortex and reversion of atropine-induced disruption of the degraded contingency effect by antipsychotic agents and N-desmethylclozapine in rats.
|
Int J Neuropsychopharmacol
|
2009
|
0.75
|